Skip to main content

Table 2 Clinical characteristics of the CLL patients (n = 90)

From: Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells

Characteristic

Frequency (%)

Sex

 Male

70

 Female

30

Age, y

 40–49

7

 50–59

7

 60–69

38

 70–79

39

 80–89

10

Clinical phase

 Progressive *

47

 Non-progressive *

53

Rai Stage

 O

39

 I

26

 II

7

 III

26

 IV

3

Treatment

 Previously treated **

33

 Previously untreated ***

67

  1. * For definition, see ref [43].
  2. ** Test performed at relapse / progression prior to initiation of salvage therapy.
  3. *** Among 60 untreated patients, 33 were indolent and 27 were progressive/symptomatic but tested prior to first-line therapy.
Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us